期刊文献+

连续性静-静脉血液滤过治疗对血液中TNF-α、IL-1、IL-6浓度的影响 被引量:3

The change of serum concentrations of TNF -α, IL-1, JL - 6 during continuous veno - venous hemofiltration therapy
下载PDF
导出
摘要 目的 探讨连续性静-静脉血液滤过治疗(CVVH)对外周血中肿瘤坏死因子(TNF-α),白介素-1(IL-1),白介素-6(IL-6)浓度的影响。方法 30例肾功能不全患者行CVVH,血滤器采用AV600(聚砜膜,1.4m^2),治疗前、治疗2h、6h、8h、结束时取血和滤波采用ELISA法测定TNF-α、IL-1、IL-6浓度。结果 CVVH过程中血液TNF-α、IL-1、IL-6浓度缓慢降低,于6h达到最低点,与治疗前对比差异显著(P<0.05)。8h后血液中TNF-α、IL-1、IL-6浓度逐渐上升。治疗结束后浓度回升至接近治疗前水平(P>0.05),滤液中始终未检测到上述因子。结论 CVVH使用聚砜膜滤过器时对血中TNF-α、IL-1、IL-6有清除作用,此种作用于CVVH治疗6小时后消失,其消除方式可能是吸附。 Objective To detect serum concentrations of tumor necrotic factor( TNF - a),interleukin - 1 (IL - 1),interleukin- 6 (IL- 6) during continuous veno- venous hemofiltration therapy(CWH) methodology.Methods Thirty patients treated with CWH,AV600 hemofilter (Polysulfone,1.4m2) was used,Blood and ultrafiltran'on fluid was sampled before and 2,6,8 hours in the process of CWH.Results During CWH procedure,TNF-a,IL-1 andIL-6 levels were decreased progressively,got to the lowest at 6 hours,which was significantly lower than 0 hourt,After 8 hours,TNF - a,IL- 1 and IL- 6 levels increase slowly,and none of the three mediators could be detected in the ultra-filtration fluid.Condution Serum TNF- a,IL-landIL-6gottothe nadir at 6 hours in the process of CWH with polysulfone hemofilter and the clearing of these mediators may be mainly through absorption but not filtration.
出处 《中国血液净化》 2002年第11期7-9,共3页 Chinese Journal of Blood Purification
关键词 连续性静-静脉血液滤过 细胞因子 Continuous veno- venous hemofilbation therapy (CWH) Cytokine
  • 相关文献

参考文献7

二级参考文献8

共引文献254

同被引文献29

  • 1孙建设,吴毓敏,张斌,司徒碧颖,陆文俊.连续性静-静脉血液滤过在老年人多脏器功能障碍时的应用[J].中国血液净化,2002,1(11):49-51. 被引量:12
  • 2刘拉羊,邓红,赵婕,李小燕.连续性肾脏替代疗法在重症肾综合征出血热少尿期的应用[J].中国血液净化,2002,1(12):19-21. 被引量:4
  • 3张永利,万献尧.连续性肾脏替代治疗在重症监护病房中的应用[J].中国呼吸与危重监护杂志,2003,2(6):382-384. 被引量:12
  • 4杜斌.对危重预后估计[A].刘大为主编.21世纪医师丛书危重病学分册:第一版[C].北京: 中国协和医科大学出版社,2000.424-430.
  • 5廖履坦 徐元钊.血液透析[A].陈灏珠主编.实用内科学: 第11版[C].北京:人民卫生出版社,2001.1971.
  • 6Schetz M. Evidence-based analysis of the use of hemofiltration in sepsis and MODS[J]. Curr Opin Crit Care,1997,3:434 - 439.
  • 7张训.CRRT与延长透析[C]..全国肾衰一体化治疗学术会议讲座[C].,2001.82-85.
  • 8Bellomo R,Baldwin I,Cloe L et al. Pre liminary experience with high-volume hemofilatration in human septic shock[J]. Kidney Int, 1998,53 :s182 - 184.
  • 9Shimon K, RMael M. Infectious complications[A]. In:Shapiro R, Simmons RL, Starzl TE, eds. Renal transplantation[M]. Stanford:Appleton & Lange, 1997. 315-331.
  • 10Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions,mechanisms, relevant outcomes, and clinical trial coordination[J]. Intensive Care Med, 1994,20(3), 228.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部